IPO registrations (S-1, F-1) · Registrants

VICURON PHARMACEUTICALS INC

SEC CIK
1052547 · filings on EDGAR ↗
Name on the registration
VERSICOR INC /CA
Former names
VERSICOR INC /CA (2000–2003)
Registration
Form S-1, first filed 2000-03-22, last 2000-07-25; 1 initial registration, 3 amendments
Outcome
Final prospectus filed 2000-08-03
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
455 SOUTH GULPH ROAD, SUITE 305, King Of Prussia, PA 19406
EIN
04-3278032
EDGAR entity type
operating

Offering terms

Proposed price range
$11.00–$13.00 per share (S-1/A filed 2000-07-25)
Final price
$11.00 per share, within the range (424B4 filed 2000-08-03, an initial public offering)
Shares sold
4,600,000
Gross proceeds
$50,600,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol VERS
Lead underwriters
Lehman Brothers (1,800,000 shares); UBS (400,000 shares); J.P. Morgan (1,000,000 shares); Pacific Growth Equities, Inc (800,000 shares); Services Corporation (60,000 shares)
Syndicate
Hambrecht & Quist; CIBC World Markets (60,000); A.G. Edwards (60,000); Robertson Stephens (60,000); Lazard (60,000); Prudential Securities (60,000); Cowen (60,000); Fahnestock & Co. Inc (30,000); Edward D. Jones & Co., L.P (30,000); Legg Mason (30,000); Raymond James (30,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 5

FiledFormWhat it isName as filedEDGAR
2000-03-22S-1S-1 (registration)VERSICOR INC /CA0000912057-00-012927 ↗
2000-06-09S-1/AS-1/A (amendment)VERSICOR INC /CA0000912057-00-028043 ↗
2000-07-05S-1/AS-1/A (amendment)VERSICOR INC /CA0000912057-00-030834 ↗
2000-07-25S-1/AS-1/A (amendment)VERSICOR INC /CA0000912057-00-033076 ↗
2000-08-03424B4424B4 (final prospectus)VERSICOR INC /CA0000912057-00-034513 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-07-25S-1/Aregistration statement$11.00–$13.004,600,000-Nasdaq VERS5primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2000-08-03424B4final prospectus$11.004,600,000$50,600,000Nasdaq VERS16primary document; price sentence, shares headline, proceeds table, underwriting table 15, cover names 3document ↗

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationVicuron Pharmaceuticals Inc.PAState business registriesname and state
Trademark ownerVicuron Pharmaceuticals Inc.PATrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Pharmaceutical Preparations · Health